CD8A and mature T-cell and NK-cell non-Hodgkin lymphoma: In PTCL, the malignant clone is most often CD4+, representing approximately two-thirds of cases, whereas CD8+ PTCLs account for only 15–25%, with the remainder typically double-negative and, more rarely, double-positive [123].